(Q37302885)

19 August 2017

1 reference

title

Phosphodiesterase genes and antidepressant treatment response: a review (English)

1 reference

19 August 2017

5

1 reference

19 August 2017

6

1 reference

19 August 2017

Karin Esposito

1

1 reference

19 August 2017

Gillian W Reierson

series ordinal

2

1 reference

19 August 2017

Huai Rong Luo

series ordinal

3

1 reference

19 August 2017

Gui Sheng Wu

series ordinal

4

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

19 August 2017

1 reference

19 August 2017

volume

41

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

177-185

1 reference

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Treatment resistant depression--advances in somatic therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Role of phosphodiesterases in neurological and psychiatric disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

PDE inhibitors in psychiatry--future options for dementia, depression and schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Phosphodiesterase 7A: a new therapeutic target for alleviating chronic inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Keynote review: phosphodiesterase-4 as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Intracellular signaling pathways pave roads to recovery for mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Axonal regeneration in adult CNS neurons--signaling molecules and pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Spatiotemporal control of cAMP signalling processes by anchored signalling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Molecular mechanisms of membrane receptor desensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Phosphodiesterases in the CNS: targets for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Identification of a noncatalytic cGMP-binding domain conserved in both the cGMP-stimulated and photoreceptor cyclic nucleotide phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

The GAF domain: an evolutionary link between diverse phototransducing proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

SMART 5: domains in the context of genomes and networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

GAF domains: two-billion-year-old molecular switches that bind cyclic nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Properties and functions of GAF domains in cyclic nucleotide phosphodiesterases and other proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Cloning and characterization of two splice variants of human phosphodiesterase 11A

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

N-Terminal domain of phosphodiesterase-11A4 (PDE11A4) decreases affinity of the catalytic site for substrates and tadalafil, and is involved in oligomerization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Phosphodiesterase 4 inhibitors for the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Effects of repeated antidepressant treatment of type 4A phosphodiesterase (PDE4A) in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: comparison with rolipram

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

In vivo and in vitro measurement of brain phosphodiesterase 4 in rats after antidepressant administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Different regulation of adenylyl cyclase and rolipram-sensitive phosphodiesterase activity on the frontal cortex and hippocampus in learned helplessness rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Is phosphodiesterase inhibition a new mechanism of antidepressant action? A double blind double-dummy study between rolipram and desipramine in hospitalized major and/or endogenous depressives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Erectile dysfunction and cardiac disease: recommendations of the Second Princeton Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Variants in PDE11A and PDE1A are not associated with citalopram response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Disrupted in schizophrenia 1 and phosphodiesterase 4B: towards an understanding of psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Genetics of recurrent early-onset major depression (GenRED): final genome scan report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

Pharmacogenomics of neuroimmune interactions in human psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802441169

10.1080/07853890802441169

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference